Back to search

Article

PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer

2020-08-07

Abstract excerpt

<h4>ABSTRACT</h4> Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include the maintenance and expansion of breast cancer stem cells (CSCs). Breast CSCs frequently exist as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
14acfb4b-dd52-5a00-ae2b-6c17d60b9216
DOI
10.1101/2020.08.07.238550
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancerDOI 10.1101/2020.08.07.238550
Select a neighboring publication to make it the new centre.